(Q42351006)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Loretta J Nastoupil

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

3

Sattva S Neelapu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

6

Nathan H Fowler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

5

Yasuhiro Oki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

4

Sheryl G Forbes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

1 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

3357-3359

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

8 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5161005

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5161005

PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5161005

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5161005

10.1182/BLOOD-2015-03-633156

29 May 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25999447%20AND%20SRC:MED&resulttype=core&format=json